Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression
Conditions
Interventions
VLS-01-203 BU
VLS-01-BU Placebo
Locations
42
United States
Noble Clinical Research
Tucson, Arizona, United States
Pillar Clinical Research, LLC
Little Rock, Arkansas, United States
Preferred Research Partners, Inc.
Little Rock, Arkansas, United States
Woodland Research Northwest
Rogers, Arkansas, United States
CenExel
Garden Grove, California, United States
Behavioral Research Specialists, LLC
Glendale, California, United States
Start Date
December 30, 2024
Primary Completion Date
March 1, 2026
Completion Date
March 30, 2026
Last Updated
February 4, 2026
NCT06731621
NCT04480918
NCT04041479
NCT03320304
NCT06895863
NCT05357040
Lead Sponsor
atai Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions